Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles

Glioblastoma multiforme (GBM), a common type of brain cancer, has a very poor prognosis. In general, viable GBM cells exhibit elevated phosphatidylserine (PS) on their membrane surface compared to healthy cells. We have developed a drug, saposin C-dioleoylphosphatidylserine (SapC-DOPS), that selecti...

Descripció completa

Dades bibliogràfiques

Autors principals:	Harold W. Davis, Subrahmanya D. Vallabhapurapu, Zhengtao Chu, Michael A. Wyder, Kenneth D. Greis, Venette Fannin, Ying Sun, Pankaj B. Desai, Koon Y. Pak, Brian D. Gray, Xiaoyang Qi
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2020-08-01
Col·lecció:	Cells
Matèries:	SapC-DOPS nanovesicles radiation therapy brain tumor glioblastoma multiforme iodination phosphatidylserine
Accés en línia:	https://www.mdpi.com/2073-4409/9/9/1960
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!